FCRL3 and rheumatoid arthritis: This analysis effectively reduced the impact of potential confounding factors, providing protein-level evidence that further supports the causal relationship between FCRL3 and RA, suggesting that targeting FCRL3 may help improve the prognosis of RA patients.